SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS THROUGH THREE YEARS: LONG-TERM RESULTS OF TWO RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDIES
Rheumatology（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要